1. Home
  2. ATCH vs SER Comparison

ATCH vs SER Comparison

Compare ATCH & SER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AtlasClear Holdings Inc.

ATCH

AtlasClear Holdings Inc.

HOLD

Current Price

$0.24

Market Cap

34.9M

Sector

N/A

ML Signal

HOLD

Logo Serina Therapeutics Inc.

SER

Serina Therapeutics Inc.

HOLD

Current Price

$1.87

Market Cap

29.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATCH
SER
Founded
2022
2017
Country
United States
United States
Employees
43
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
34.9M
29.3M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
ATCH
SER
Price
$0.24
$1.87
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$13.00
AVG Volume (30 Days)
6.9M
3.6M
Earning Date
02-13-2026
03-23-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.03
N/A
Revenue
$14,613,715.00
$116,000.00
Revenue This Year
N/A
$134.46
Revenue Next Year
N/A
N/A
P/E Ratio
$7.72
N/A
Revenue Growth
52.99
N/A
52 Week Low
$0.14
$1.65
52 Week High
$13.19
$7.92

Technical Indicators

Market Signals
Indicator
ATCH
SER
Relative Strength Index (RSI) 44.31 35.44
Support Level $0.23 $1.65
Resistance Level $0.28 $3.14
Average True Range (ATR) 0.02 0.36
MACD 0.00 -0.12
Stochastic Oscillator 28.52 7.38

Price Performance

Historical Comparison
ATCH
SER

About ATCH AtlasClear Holdings Inc.

AtlasClear Holdings Inc is a fintech company. Its goal is to build a cutting-edge technology-enabled financial services firm that would create a more efficient platform for trading, clearing, settlement, and banking of evolving and financial products with a focus on financial services firms. It is a fintech-driven business-to-business platform that expects to power innovation in fintech, investing, and trading. The company believes it is positioned to provide a modern, mission-critical suite of solutions to its clients, enabling them to reduce their transaction costs and compete more effectively in their businesses.

About SER Serina Therapeutics Inc.

Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The Company has one reportable segment relating to the research and development of its POZ platform.

Share on Social Networks: